Non- Interventional Study on Stroke Estimation (According to Framingham Profile ParameterS) in Patients Under medicAtion Due to Essential Hypertension (NASA)
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Eprosartan (Primary)
- Indications Essential hypertension; Stroke
- Focus Therapeutic Use
- Acronyms NASA
- Sponsors Abbott Laboratories
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Dec 2012 Planned End Date changed from 1 Feb 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 26 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.